NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 8 filers reported holding NLS PHARMACEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,747,126 | $3,970,689 | 0.11% |
| Affinity Asset Advisors, LLC | 200,455 | $140,319 | 0.04% |
| J. Goldman & Co LP | 254,601 | $178,221 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 90 | $63 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56,549 | $39,584 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,362 | $9,922 | 0.00% |
| Renaissance Technologies | 21,100 | $15 | 0.00% |